Comparison of Serum Albumin Separation by Ammonium Sulfate Precipitation and Cibacron Blue Affinity Chromatography
Abstract
Keywords
: Serum Albumin , Ammonium Sulfate , Cibacron Blue F3GA , Affinity Chromatography , Protein Fractionation
References
- [1] Quinlan GJ, Martin GS, Evans TW. Albumin: Biochemical properties and therapeutic potential. Hepatology, 2005;41:1211–9.
- [2] Farrugia A. Albumin Usage in Clinical Medicine: Tradition or Therapeutic? Transfus Med Rev, 2010;24(1):53–63.
- [3] Raoufinia R, Mota A, Nozari S, Aghebati Maleki L, Balkani S, Abdolalizadeh J. A methodological approach for purification and characterization of human serum albumin. J Immunoassay Immunochem, 2016;37(6):601–14.
- [4] Peters TJ. Metabolism: Albumin in the body. In: All About Albumin. Biochemistry, Genetics, and Medical Application, San Diego: Academic Press. 1996.
- [5] Evans TW. Review article: Albumin as a drug - Biological effects of albumin unrelated to oncotic pressure. Aliment Pharmacol Ther Suppl, 2002;16(Suppl 5):6–11.
- [6] Mendez CM, McClain CJ, Marsano LS. Albumin therapy in clinical practice. Nutr Clin Pract, 2005;20(3):314–20.
- [7] Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature. Nutr J, 2010;9:69.
- [8] Denizli A. Plasma fractionation: conventional and chromatographic methods for albumin purification. Hacettepe Journal of Biology and Chemistry, 2011;39(394):315–41.
- [9] Koga M, Kasayama S. Clinical impact of glycated albumin as another glycemic control marker. Endocrine Journal, 2010;57(9):751–62.
- [10] Sbarouni E, Georgiadou P, Voudris V. Ischemia modified albumin changes - Review and clinical implications. Clinical Chemistry and Laboratory Medicine, 2011;49(2):177–84.